NEW YORK, June 25 - Ciphergen Biosystems has agreed to acquire BioSepra, a French chromatography equipment business, from Invitrogen for $12 million in cash, the companies said Monday.

Ciphergen said the acquisition would position it to develop protein purification products for the benchtop biology equipment market and provide additional capabilities for its ProteinChip protein screening and identification platform.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.